Lion Point Capital »

Cue Biopharma shares owned by Lion Point Capital

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $673k 2.2M 0.31

More positions owned by Lion Point Capital

Milestone Pharmaceuticals (MIST)
Praxis Precision Medicines I Com New (PRAX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Fennec Pharmaceuticals (FENC)
Jasper Therapeutics Com New (JSPR)
Benitec Biopharma Com New (BNTC)
Royalty Pharma Shs Class A (RPRX)
Geron Corporation (GERN)
Syndax Pharmaceuticals (SNDX)
Ardelyx (ARDX)
Cue Biopharma (CUE)
Disc Medicine (IRON)
Sarepta Therapeutics (SRPT)
Biohaven (BHVN)
Humacyte (HUMA)

View all positions for Lion Point Capital

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Group
Lion Point Capital
Geode Capital Management
Boothbay Fund Management
Robertson Stephens Wealth Management
BlackRock
Texas Capital Bank Wealth Management Services
Advisory Research
Stifel Financial
Renaissance Technologies
State Street Corporation
Susquehanna International
Angeles Wealth Management

View all funds holding Cue Biopharma